Ventyx Biosciences Inc (VTYX) — Financial Flexibility Index
Ventyx Biosciences Inc (VTYX) has a Financial Flexibility Index of -0.87x as of September 2025. Free cash flow of $-17.46 Million (operating CF $-17.51 Million minus capex $50.00K) represents -1% of total liabilities ($20.10 Million). Check Ventyx Biosciences Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ventyx Biosciences Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Ventyx Biosciences Inc across 6 annual periods. See VTYX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Ventyx Biosciences Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Ventyx Biosciences Inc. For the full company profile including market capitalisation, see market value of Ventyx Biosciences Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.80x | $-130.63 Million | $-130.87 Million | $22.52 Million | ▼ -18.0% |
| 2023 | -4.92x | $-166.01 Million | $-166.52 Million | $33.77 Million | ▲ +12.6% |
| 2022 | -5.63x | $-98.50 Million | $-98.77 Million | $17.50 Million | ▼ -80.0% |
| 2021 | -3.13x | $-38.39 Million | $-38.65 Million | $12.28 Million | ▼ -1527.7% |
| 2020 | -0.19x | $-5.93 Million | $-6.20 Million | $30.90 Million | ▲ +63.9% |
| 2019 | -0.53x | $-2.38 Million | $-2.64 Million | $4.48 Million | — |